PATENT CLAIM ANALYSIS

Application Number: 15776698
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "685000"]

Abstract:
The invention relates to the use of a compound of Formula (I) as described herein and its effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.

Claim (Index 2):
The method of  claim 1 , wherein m is 0; R 1  is halogen; n is any integer of 1-4; R 3  is H; X is \u2014C(O)\u2014; R 4  is H; and R 5  is OH; C 3-8 cycloalkyl; phenyl unsubstituted or substituted with one to three same or different substituents selected from OH, CN, halogen, NH 2  or C 1-4 alkylpiperazinyl; C 1-6 alkylpiperazinyl; C 1-6 alkylpyridinyl; C 1-6 alkylpyrrolidinyl; pyridinyl; pyrimidinyl; pyrazinyl; piperazinyl; pyrrolidinyl; thiazolyl; benzimidazolyl; pyrazolyl; indazolyl; pyrazolyl; quinolinyl; indolyl; C 1-4 indolyl; indazolyl; azaindolyl; azaindazolyl; deazapurinyl; indanyl; morpholinoyl or C 1-4 alkylmorpholinoyl, each of which is unsubstituted or substituted with one, two or three groups selected from OH, CN, halogen or NH 2 .

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15746964', '10399231', '15300762', '16308041', '14769421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816128972297429
- 35 USC 102 Novelty (BERT): 0.5437995958527708
- Combined Prediction Score: 0.7578315670920457
- Mean Citation Score: 288.404012
- Max Citation Score: 385.9365
- Similarity Product: 378.2499824123384

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test